This protocol is judged by an institutional assessment board, an independent team that testimonials any clinical trials involving humans. If a review will involve a Program I drug, after the board approves the protocol as moral, the researchers need to apply for an investigational new drug (IND) selection through the FDA.This text features a list o… Read More